Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a Canada-based specialty pharmaceutical company. The Company's principal business activity includes developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invested in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The Company's portfolio consists of pharmaceutical products with molecules and includes both in-licensed products, such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome as well as products owned (or partially owned) by it, such as Exelon and Impavido.


TSX:GUD - Post by User

Comment by porksnifferon Nov 27, 2020 9:06pm
92 Views
Post# 31993470

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:While other biotech steam forward. DUG looks behind the

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:While other biotech steam forward. DUG looks behind the
MrMugsy wrote: Porky ... the only low I'm hitting is wasting my time with this strange back-and-forth.

???

You mentioned "better lucky than smart" and I remind you where that comes from.

In the 2014 video where Goodman mentions that his dad was in pharma and that Jonnathan became a pharma delivery boy.  He then said, if his dad was in dry cleaning, Jonnathan would likely have become a dry cleaning delivery boy.

Hence, better luck than smart ... that his dad was in pharma.  Do you understand ?

I'm not saying I'm better than you.
I'm not trying to make you feel bad.
I'm giving you facts.
I'm always giving you facts when you make strange suggestions that Goodman will be gone.
It's not me idolizing Goodman ... it's me telling you that there aren't enough votes on this planet to remove Goodman.

Surely you understand what I'm saying?



Not everyone has seen every video every interview JRG has said or done. Palladin this/that, videos from 2014. As the prospectus says "past performance is no indication of future returns". We get it management won't get voted out, Move on man, you're a broken record.
<< Previous
Bullboard Posts
Next >>